Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

SZSE:002864 Stock Report

Market Cap: CN¥3.0b

Shaanxi Panlong Pharmaceutical Group Limited By Share Past Earnings Performance

Past criteria checks 4/6

Shaanxi Panlong Pharmaceutical Group Limited By Share has been growing earnings at an average annual rate of 10.8%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 11.6% per year. Shaanxi Panlong Pharmaceutical Group Limited By Share's return on equity is 7.2%, and it has net margins of 11.8%.

Key information

10.8%

Earnings growth rate

7.6%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate11.6%
Return on equity7.2%
Net Margin11.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings

May 02
We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings

Recent updates

There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding

Sep 30
There Is A Reason Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's (SZSE:002864) Price Is Undemanding

Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year

May 31
Shaanxi Panlong Pharmaceutical Group Limited By Share's (SZSE:002864) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings

May 02
We Think That There Are Some Issues For Shaanxi Panlong Pharmaceutical Group Limited By Share (SZSE:002864) Beyond Its Promising Earnings

Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Mar 06
Earnings Not Telling The Story For Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SZSE:002864) After Shares Rise 32%

Revenue & Expenses Breakdown

How Shaanxi Panlong Pharmaceutical Group Limited By Share makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002864 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2498211644828
30 Jun 2493611643624
31 Mar 2496512043921
31 Dec 2398111042320
30 Sep 2399710744225
30 Jun 231,04311145125
31 Mar 231,00110342519
01 Jan 2397410142418
30 Sep 229589840417
30 Jun 229179638815
31 Mar 229119639914
01 Jan 228879339114
30 Sep 218428638814
30 Jun 218348937713
31 Mar 217648734813
31 Dec 206707930913
30 Sep 206268029612
30 Jun 205656629113
31 Mar 205717029813
31 Dec 196117232613
30 Sep 19587763218
30 Jun 195647230710
31 Mar 19516672959
31 Dec 18489652798
30 Sep 18442572499
30 Jun 18424562349
31 Mar 18404462168
31 Dec 17377442007
30 Sep 17369491824
30 Jun 17333441650
31 Mar 17305401470
31 Dec 16305401430
31 Dec 15256431140
31 Dec 14246401240
31 Dec 13227331180

Quality Earnings: 002864 has high quality earnings.

Growing Profit Margin: 002864's current net profit margins (11.8%) are higher than last year (10.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002864's earnings have grown by 10.8% per year over the past 5 years.

Accelerating Growth: 002864's earnings growth over the past year (8%) is below its 5-year average (10.8% per year).

Earnings vs Industry: 002864 earnings growth over the past year (8%) exceeded the Pharmaceuticals industry -1.2%.


Return on Equity

High ROE: 002864's Return on Equity (7.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies